The senescence-associated secretory phenotype and its physiological and pathological implications
Nature Reviews Molecular Cell BiologyCellular senescence is a state of terminal growth arrest associated with the upregulation of different cell cycle inhibitors, mainly p16 and p21, structural and metabolic alterations, chronic DNA damage responses, and a hypersecretory state known as the senescence-associated secretory phenotype (SASP).
Jin Han +2 more
exaly +3 more sources
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype [PDF]
Cellular senescence permanently arrests cell proliferation, often accompanied by a multi-faceted senescence-associated secretory phenotype (SASP). Loss of mitochondrial function can drive age-related declines in the function of many post-mitotic tissues,
Judith Campisi +2 more
exaly +2 more sources
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Science Translational Medicine, 2016Senescent cells encourage abnormal blood vessels and retinal disease.
Malika, Oubaha +11 more
openaire +2 more sources
NLRP1 inflammasome modulates senescence and senescence-associated secretory phenotype
2023Abstract Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as the senescence-associated secretory phenotype (SASP). Here, we present evidence that the inflammasome sensor, NLRP1, is a key mediator of senescence induced by ...
Ines, Muela-Zarzuela +12 more
openaire +2 more sources
Detection of the Senescence-Associated Secretory Phenotype (SASP)
2012Cellular senescence suppresses cancer by eliminating potentially oncogenic cells, participates in tissue repair, contributes to cancer therapy, and promotes organismal aging. Numerous activities of senescent cells depend on the aptitude of these cells to secrete myriads of bioactive molecules, a behavior termed the senescence-associated secretory ...
openaire +2 more sources
Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype
Chemico-Biological Interactions, 2018Senescence is one of the hallmarks of aging and identified as a potential therapeutic target in the treatment of aging and aging-related diseases. Senescent cells accumulate with age in a variety of human tissues where they develop a complex senescence-associated secretory phenotype (SASP). SASP in brain could contribute to age-related inflammation and
Jingang, Hou +4 more
openaire +2 more sources
Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP)
2018Cellular senescence is linked to many normal biological processes, including tumor suppression, development, and wound healing, but it is also associated with age-related pathologies such as cancer progression. Numerous functions of senescent cells depend on their ability to secrete bioactive molecules, a characteristic termed the senescence-associated
Nicolas, Malaquin +2 more
openaire +2 more sources
Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging
InflammopharmacologyOsteoarthritis (OA) is a common joint condition correlated with aging, characterized by the gradual degradation of cartilage, alterations in the subchondral bone, and ongoing low-level inflammation. There is growing evidence that the senescence-associated secretory phenotype (SASP) of chondrocytes, which includes the continuous release of IL1β, IL6 ...
Muhammad Afzal +9 more
openaire +2 more sources
Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP)
Dual-faced cellular senescence is responsible for beneficial biological processes and for age-related pathologies. Senescent cells under stable proliferation arrest develop numerous senescence-associated phenotypes such as the potent pro-inflammatory secretome called the senescence-associated secretory phenotype (SASP).Nicolas, Malaquin, Francis, Rodier
openaire +2 more sources
Regulation of the senescence-associated secretory phenotype by the nucleoporin TPR
2022Trabajo presentado en el yICSA Senescence Symposium, celebrado en Londres (Inglaterra) el 29 de abril de 2022.
Bartlett, Bethany +4 more
openaire +1 more source

